First Time Loading...

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 5.2194 USD 0.96%
Updated: May 3, 2024
AUPH
/
Income Statement
/
Revenue

Aurinia Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
ZYME
TH
RPTX
FUSN
EDT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$175.5m
CAGR 3-Years
52%
CAGR 5-Years
223%
CAGR 10-Years
68%
Zymeworks Inc
NYSE:ZYME
Revenue
$76m
CAGR 3-Years
25%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Revenue
$78.1m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
27%
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Revenue
$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-5%

Aurinia Pharmaceuticals Inc
Revenue Breakdown

Breakdown by Geography
Aurinia Pharmaceuticals Inc

Total Revenue: 175.5m USD
100%
United States: 158m USD
90%
Japan: 17.6m USD
10%

Breakdown by Segments
Aurinia Pharmaceuticals Inc

Total Revenue: 175.5m USD
100%
Product Revenue, Net: 158.5m USD
90.3%
License, Collaboration And Royalty Revenue: 17m USD
9.7%

See Also

What is Aurinia Pharmaceuticals Inc's Revenue?
Revenue
175.5m USD

Based on the financial report for Dec 31, 2023, Aurinia Pharmaceuticals Inc's Revenue amounts to 175.5m USD.

What is Aurinia Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
68%

Over the last year, the Revenue growth was 31%. The average annual Revenue growth rates for Aurinia Pharmaceuticals Inc have been 52% over the past three years , 223% over the past five years , and 68% over the past ten years .

ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.